KORU Medical Systems, Inc. (NASDAQ:KRMD) Receives Average Recommendation of “Moderate Buy” from Brokerages

KORU Medical Systems, Inc. (NASDAQ:KRMD) has been assigned a consensus rating of “Moderate Buy” from the five brokerages that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $7.25.

Several brokerages have recently issued reports on KRMD. B. Riley Financial upped their price objective on KORU Medical Systems from $7.00 to $8.00 and gave the stock a “buy” rating in a report on Friday, March 13th. Canaccord Genuity Group reissued a “buy” rating and issued a $6.00 target price on shares of KORU Medical Systems in a report on Friday, March 13th. Weiss Ratings upgraded shares of KORU Medical Systems from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, June 24th. Finally, Wall Street Zen raised shares of KORU Medical Systems from a “hold” rating to a “buy” rating in a research note on Saturday.

Insider Buying and Selling at KORU Medical Systems

In other KORU Medical Systems news, insider Adam R. Kalbermatten bought 12,500 shares of the firm’s stock in a transaction dated Thursday, June 11th. The shares were purchased at an average cost of $3.94 per share, for a total transaction of $49,250.00. Following the transaction, the insider owned 312,500 shares of the company’s stock, valued at $1,231,250. This represents a 4.17% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In the last 90 days, insiders have bought 28,000 shares of company stock valued at $109,430. Insiders own 18.50% of the company’s stock.

Institutional Investors Weigh In On KORU Medical Systems

Several large investors have recently added to or reduced their stakes in KRMD. Acuitas Investments LLC boosted its holdings in shares of KORU Medical Systems by 89.6% in the 3rd quarter. Acuitas Investments LLC now owns 763,088 shares of the company’s stock worth $2,923,000 after purchasing an additional 360,594 shares during the period. Simcoe Capital LLC purchased a new stake in KORU Medical Systems during the 4th quarter valued at $3,921,000. Vanguard Group Inc. raised its holdings in KORU Medical Systems by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 2,145,772 shares of the company’s stock valued at $8,218,000 after buying an additional 60,109 shares during the period. Geode Capital Management LLC lifted its position in KORU Medical Systems by 101.3% in the second quarter. Geode Capital Management LLC now owns 997,147 shares of the company’s stock worth $3,571,000 after buying an additional 501,875 shares during the last quarter. Finally, Jane Street Group LLC boosted its stake in KORU Medical Systems by 136.7% during the first quarter. Jane Street Group LLC now owns 163,137 shares of the company’s stock worth $414,000 after buying an additional 94,214 shares during the period. 58.60% of the stock is owned by institutional investors.

KORU Medical Systems Stock Performance

KORU Medical Systems stock remained flat at $4.49 during midday trading on Friday. The company had a trading volume of 116,470 shares, compared to its average volume of 161,213. The business’s 50 day moving average price is $4.07 and its two-hundred day moving average price is $4.67. KORU Medical Systems has a 52 week low of $2.91 and a 52 week high of $6.61. The company has a market cap of $206.23 million, a PE ratio of -89.80 and a beta of 0.41.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.